Suppr超能文献

微小RNA如何影响遗传性和炎症介导的结肠癌。

How microRNAs influence both hereditary and inflammatory-mediated colon cancers.

作者信息

Hutchison Jennifer, Cohen Zoe, Onyeagucha Benjamin C, Funk Janet, Nelson Mark A

机构信息

Physiological Sciences Interdisciplinary Program, University of Arizona, Tucson, Arizona, USA.

出版信息

Cancer Genet. 2013 Sep-Oct;206(9-10):309-16. doi: 10.1016/j.cancergen.2013.06.005. Epub 2013 Sep 14.

Abstract

MicroRNAs have emerged as important post-translational regulators of gene expression and are involved in several physiological and pathological states including the pathogenesis of human colon cancers. In regards to tumor development, microRNAs can act as oncogenes or tumor suppressors. Two hereditary predispositions (i.e., Lynch syndrome and familial adenomatous polyposis) contribute to the development of colon cancer. In addition, individuals who suffer from inflammatory bowel diseases such as Crohn's disease or ulcerative colitis have a higher risk of developing colon cancer. Here, we discuss the occurrence of the deregulated expression of microRNAs in colon cancer that arise as a result of hereditary predisposition and inflammatory bowel disease.

摘要

微小RNA已成为基因表达重要的翻译后调节因子,并参与多种生理和病理状态,包括人类结肠癌的发病机制。在肿瘤发展方面,微小RNA可作为癌基因或肿瘤抑制因子。两种遗传易感性(即林奇综合征和家族性腺瘤性息肉病)促成结肠癌的发生。此外,患有诸如克罗恩病或溃疡性结肠炎等炎症性肠病的个体患结肠癌的风险更高。在此,我们讨论因遗传易感性和炎症性肠病导致的结肠癌中微小RNA表达失调的情况。

相似文献

1
How microRNAs influence both hereditary and inflammatory-mediated colon cancers.
Cancer Genet. 2013 Sep-Oct;206(9-10):309-16. doi: 10.1016/j.cancergen.2013.06.005. Epub 2013 Sep 14.
2
Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: an ECCO CONFER Multicentre Case Series.
J Crohns Colitis. 2022 Dec 5;16(12):1845-1852. doi: 10.1093/ecco-jcc/jjac094.
3
[Early detection of colorectal carcinoma. Pros and cons].
MMW Fortschr Med. 2005 Apr 7;147(14):26-8.
4
The genetics of hereditary colon cancer.
Genes Dev. 2007 Oct 15;21(20):2525-38. doi: 10.1101/gad.1593107.
5
Hereditary and familial colon cancer.
Gastroenterology. 2010 Jun;138(6):2044-58. doi: 10.1053/j.gastro.2010.01.054.
7
Working through a diagnostic challenge: colonic polyposis, Amsterdam criteria, and a mismatch repair mutation.
Fam Cancer. 2008;7(4):281-5. doi: 10.1007/s10689-007-9179-z. Epub 2008 Jan 6.
8
[Screening for colon cancer].
Duodecim. 1994;110(20):1919-24.
10
[Hereditary gastrointestinal neoplasias].
Z Gastroenterol. 2005 Feb;43(2):219-25. doi: 10.1055/s-2004-813928.

引用本文的文献

2
and epithelial mesenchymal transition in human gastric cancers: An update of the literature.
Heliyon. 2023 Aug 6;9(8):e18945. doi: 10.1016/j.heliyon.2023.e18945. eCollection 2023 Aug.
3
Differentially Deregulated MicroRNAs as Novel Biomarkers for Neoplastic Progression in Ulcerative Colitis.
Clin Transl Gastroenterol. 2022 Jul 1;13(7):e00489. doi: 10.14309/ctg.0000000000000489. Epub 2022 Apr 8.
4
Eicosapentaenoic acid's metabolism of 15-LOX-1 promotes the expression of miR-101 thus inhibits Cox2 pathway in colon cancer.
Onco Targets Ther. 2020 Jun 15;13:5605-5616. doi: 10.2147/OTT.S237562. eCollection 2020.
5
Colorectal Cancer and Alcohol Consumption-Populations to Molecules.
Cancers (Basel). 2018 Jan 30;10(2):38. doi: 10.3390/cancers10020038.
6
MicroRNA-645 is an oncogenic regulator in colon cancer.
Oncogenesis. 2017 May 15;6(5):e335. doi: 10.1038/oncsis.2017.37.
7
Tumor suppressor genes in familial adenomatous polyposis.
Gastroenterol Hepatol Bed Bench. 2017 Winter;10(1):3-13.
8
Expression of MCRS1 and MCRS2 and their correlation with serum carcinoembryonic antigen in colorectal cancer.
Exp Ther Med. 2016 Aug;12(2):589-596. doi: 10.3892/etm.2016.3424. Epub 2016 Jun 3.
9
Molecular approach to genetic and epigenetic pathogenesis of early-onset colorectal cancer.
World J Gastrointest Oncol. 2016 Jan 15;8(1):83-98. doi: 10.4251/wjgo.v8.i1.83.
10
MicroRNAs as biomarkers and prospective therapeutic targets in colon and pancreatic cancers.
Tumour Biol. 2016 Jan;37(1):97-104. doi: 10.1007/s13277-015-4346-6. Epub 2015 Nov 4.

本文引用的文献

1
A genetic variant in miR-146a modifies colorectal cancer susceptibility in a Chinese population.
Arch Toxicol. 2013 May;87(5):825-33. doi: 10.1007/s00204-012-1004-2. Epub 2013 Jan 10.
3
High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer.
Eur J Cancer. 2013 Feb;49(3):604-15. doi: 10.1016/j.ejca.2012.09.031. Epub 2012 Oct 22.
4
MicroRNAs as Novel Biomarkers in Colorectal Cancer.
Front Genet. 2012 Oct 19;3:180. doi: 10.3389/fgene.2012.00180. eCollection 2012.
5
Adrenaline promotes cell proliferation and increases chemoresistance in colon cancer HT29 cells through induction of miR-155.
Biochem Biophys Res Commun. 2012 Nov 16;428(2):210-5. doi: 10.1016/j.bbrc.2012.09.126. Epub 2012 Oct 1.
6
Ulcerative colitis.
Lancet. 2012 Nov 3;380(9853):1606-19. doi: 10.1016/S0140-6736(12)60150-0. Epub 2012 Aug 20.
8
Plasma miR-21: a potential diagnostic marker of colorectal cancer.
Ann Surg. 2012 Sep;256(3):544-51. doi: 10.1097/SLA.0b013e318265bd6f.
9
The oncogenic role of miR-155 in breast cancer.
Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1236-43. doi: 10.1158/1055-9965.EPI-12-0173. Epub 2012 Jun 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验